JANKU FILIP (Chief Medical Officer) sold 8.2% of their position (5.41K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $132.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/1/2026ACC: 0001193125-26-292767
Officer· Chief Medical Officer
Since Jun 2021
-5.41K
Net shares
Net seller
$132.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.41K acquired · 10.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.41K
Price / share
$13.41
Trade value
$72.51K
% of position
8.9%
6/30/2026
60.61K→66.02K
Common Stock
Direct
Shares
−5.41K
Price / share
$24.50
Trade value
$132.47K
% of position
8.2%
6/30/2026
66.02K→60.61K
Total
Net shares
+0.00
Net value
-$59.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | M · Option Exercise | +5.41K | $13.41 | $72.51K | 8.9% | 60.61K | 66.02K |
| Common Stock Direct | 6/30/2026 | S · Sale | −5.41K | $24.50 | $132.47K | 8.2% | 66.02K | 60.61K |
| Total | +0.00 | -$59.96K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.41K shares
Shares
−5.41K
Strike price
13.41
Held after
81.09K
Exercisable
—
6/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.41K shares | 6/30/2026 | M · Option Exercise | −5.41K | 13.41 | — | 81.09K |